Chemical formula: C₁₈H₂₁NO₃ Molecular mass: 299.364 g/mol PubChem compound: 5284371
Codeine interacts in the following cases:
Concomitant use of opioids and benzodiazepines or other CNS depressants, including alcohol, may result in sedation, respiratory depression, coma and death. Because of these risks, concomitant prescribing of codeine with CNS depressant medicines, such as other opioid analgesics, benzodiazepines, gabapentinoids, cannabis, sedatives, hypnotics, tricyclic antidepressants, antipsychotics, antihistamines, centrally active anti-emetics and other CNS depressants, should be reserved for patients for whom other treatment options are not possible. If a decision is made to prescribe codeine concomitantly with any of the medicines, the lowest effective dose should be used, and the duration of treatment should be as short as possible. Patients should be followed closely for signs and symptoms of respiratory depression and sedation. Patients and their caregivers should be made aware of these symptoms. Patients and their caregivers should also be informed of the potential harms of consuming alcohol while taking codeine.
Codeine phosphate should be used in caution in renal impairment.
Enhanced sedative effect.
Opioid antagonists e.g. buprenorphine, naltrexone, naloxone – may precipitate withdrawal symptoms.
Antidiarrhoeal drugs (e.g. loperamide, kaolin) - increased risk of severe constipation.
Enhanced hypotensive effect.
Enhanced sedative and hypotensive effect.
Antipsychotics, including phenothiazines – enhanced sedative and hypotensive effect.
Enhanced sedative effect, increased risk of respiratory depression.
Risk of severe constipation which may lead to paralytic ileus and/or urinary retention.
Cimetidine inhibits the metabolism of opioid analgesics causing increased plasma concentration of codeine.
Avoid premedication with opioids as they reduce plasma ciprofloxacin concentration.
Antagonistic effect on GI activity.
Delayed absorption of mexiletine.
Quinidine reduces the analgesic effect of codeine.
Ritonavir may increase plasma levels of opioid analgesics.
Terbinafine may reduce the activity of codeine by inhibiting the production of its active metabolite.
Opioids may cause biliary obstructions. Avoid in biliary disorders.
Codeine should be used in caution in drug abuse or dependence (including alcoholism).
Codeine should be used in caution in prostatic hypertrophy.
Opioids may stimulate catecholamine release by inducing the release of endogenous histamine.
Codeine should be used in caution in impaired respiratory function (avoid in chronic obstructive pulmonary disease) and asthma (avoid during an acute attack).
Codeine should be used in caution in adrenocortical insufficiency, e.g. Addison’s Disease.
Use with caution after recent GI surgery as codeine may alter GI mobility.
Following recent surgery patient will be more prone to urinary retention caused directly by spasm of the urethral sphincter, and via constipation caused by codeine.
Codeine should be used in caution in hypothyroidism.
Codeine should be used in caution in hypotension and shock.
Convulsions – may be induced or exacerbated.
Codeine should be used in caution in myasthenia gravis.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.